Feng-fei Li

895 total citations
50 papers, 725 citations indexed

About

Feng-fei Li is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Feng-fei Li has authored 50 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Feng-fei Li's work include Diabetes Management and Research (24 papers), Diabetes Treatment and Management (19 papers) and Pancreatic function and diabetes (16 papers). Feng-fei Li is often cited by papers focused on Diabetes Management and Research (24 papers), Diabetes Treatment and Management (19 papers) and Pancreatic function and diabetes (16 papers). Feng-fei Li collaborates with scholars based in China, Singapore and Germany. Feng-fei Li's co-authors include Jianhua Ma, Tingting Zhu, Yaohua Zhao, Yanhua Diao, Xiaofei Su, Lei Ye, Jin-dan Wu, Bijun Chen, Rengna Yan and Yun Hu and has published in prestigious journals such as PLoS ONE, Diabetes Care and Journal of Cleaner Production.

In The Last Decade

Feng-fei Li

49 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng-fei Li China 16 304 218 137 111 108 50 725
Xiaohui Huang China 15 39 0.1× 68 0.3× 214 1.6× 36 0.3× 55 0.5× 39 756
Mohit Agrawal India 10 105 0.3× 123 0.6× 33 0.2× 14 0.1× 15 0.1× 79 553
Mingyun Chen China 14 66 0.2× 45 0.2× 94 0.7× 19 0.2× 12 0.1× 32 509
Xiangqian Qi China 17 65 0.2× 187 0.9× 190 1.4× 32 0.3× 9 0.1× 37 875
Chengbiao Zhang China 16 192 0.6× 78 0.4× 657 4.8× 11 0.1× 35 0.3× 34 990
Na Yang China 16 58 0.2× 30 0.1× 278 2.0× 6 0.1× 25 0.2× 64 743
Qiu Han China 13 52 0.2× 25 0.1× 87 0.6× 8 0.1× 20 0.2× 56 486
Jinghan Xu China 10 160 0.5× 62 0.3× 68 0.5× 16 0.1× 4 0.0× 44 537
Xingzhi Guo China 16 59 0.2× 54 0.2× 271 2.0× 2 0.0× 87 0.8× 48 773

Countries citing papers authored by Feng-fei Li

Since Specialization
Citations

This map shows the geographic impact of Feng-fei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng-fei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng-fei Li more than expected).

Fields of papers citing papers by Feng-fei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng-fei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng-fei Li. The network helps show where Feng-fei Li may publish in the future.

Co-authorship network of co-authors of Feng-fei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Feng-fei Li. A scholar is included among the top collaborators of Feng-fei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng-fei Li. Feng-fei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yunting, Yuming Wang, Huiying Wang, et al.. (2022). Perilipin 2 Protects against Lipotoxicity‐Induced Islet Fibrosis by Inducing Islet Stellate Cell Activation Phenotype Changes. BioMed Research International. 2022(1). 4581405–4581405. 1 indexed citations
2.
Jiang, Lanlan, Peng Zhang, Bingli Liu, et al.. (2021). Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open‐Labeled Trial. BioMed Research International. 2021(1). 6618257–6618257. 2 indexed citations
3.
Hu, Yun, Bo Ding, Yun Shen, et al.. (2021). Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin. Diabetes Care. 44(4). 1059–1061. 32 indexed citations
4.
Zhou, Yunting, Huiying Wang, Shanhu Qiu, et al.. (2021). Vitamin A and Its Multi-Effects on Pancreas: Recent Advances and Prospects. Frontiers in Endocrinology. 12. 620941–620941. 17 indexed citations
5.
Ding, Bo, et al.. (2020). Men with Latent Autoimmune Diabetes and Type 2 Diabetes May Have Different Change Patterns in Free Testosterone. BioMed Research International. 2020(1). 6259437–6259437.
6.
Zhou, Yunting, Wei Li, Juan Chen, et al.. (2019). Lipotoxicity reduces β cell survival through islet stellate cell activation regulated by lipid metabolism-related molecules. Experimental Cell Research. 380(1). 1–8. 12 indexed citations
7.
Hu, Yun, Danfeng Zhang, Lu Dai, et al.. (2018). Pre-exercise blood glucose affects glycemic variation of aerobic exercise in patients with type 2 diabetes treated with continuous subcutaneous insulin infusion. Diabetes Research and Clinical Practice. 141. 98–105. 6 indexed citations
8.
Li, Feng-fei, Bo Ding, Rui Sun, et al.. (2018). Insulin Injection Technique is Associated with Glycemic Variability in Patients with Type 2 Diabetes. Diabetes Therapy. 9(6). 2347–2356. 13 indexed citations
9.
Li, Feng-fei, Wenli Zhang, Wei Chen, et al.. (2018). Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy. Scientific Reports. 8(1). 5888–5888. 9 indexed citations
10.
Li, Feng-fei, Rengna Yan, Danfeng Zhang, et al.. (2018). Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes. Scientific Reports. 8(1). 9713–9713. 5 indexed citations
11.
Li, Feng-fei, Honghong Zhu, Ting Li, et al.. (2017). Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men. Journal of Diabetes Research. 2017. 1–8. 13 indexed citations
12.
Li, Feng-fei, Rengna Yan, Honghong Zhu, et al.. (2017). Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values. Scientific Reports. 7(1). 1583–1583. 12 indexed citations
13.
Li, Feng-fei, Yun Shen, Rui Sun, et al.. (2017). Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes. Diabetes Therapy. 8(5). 1111–1122. 10 indexed citations
14.
15.
Zhu, Tingting, et al.. (2016). Thermal performance of new flat plate solar air heater based on micro-heat pipe arrays (MHPA). Nongye gongcheng xuebao. 32(11). 250–257. 5 indexed citations
16.
17.
Li, Feng-fei, Liyuan Fu, Xiaofei Su, et al.. (2016). Analysis of the add-on effect of α-glucosidase inhibitor, acarbose in insulin therapy: A pilot study. Biomedical Reports. 5(4). 461–466. 11 indexed citations
18.
Yang, Jiayue, Ling Li, Dimitri Aristotle Raptis, et al.. (2014). Pancreatic stone protein/regenerating protein (PSP/reg): a novel secreted protein up-regulated in type 2 diabetes mellitus. Endocrine. 48(3). 856–862. 28 indexed citations
19.
Li, Feng-fei, Bijun Chen, Ling Li, et al.. (2013). INS-1 cells inhibit the production of extracellular matrix from pancreatic stellate cells. Journal of Molecular Histology. 45(3). 321–327. 3 indexed citations
20.
Wang, Shaohua, Yang Yuan, Wenqing Xia, et al.. (2012). Neuronal Apoptosis and Synaptic Density in the Dentate Gyrus of Ischemic Rats’ Response to Chronic Mild Stress and the Effects of Notch Signaling. PLoS ONE. 7(8). e42828–e42828. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaohui Huang Breakdown of academic impact, for papers by Mohit Agrawal Breakdown of academic impact, for papers by Mingyun Chen Breakdown of academic impact, for papers by Xiangqian Qi Breakdown of academic impact, for papers by Chengbiao Zhang Breakdown of academic impact, for papers by Na Yang Breakdown of academic impact, for papers by Qiu Han Breakdown of academic impact, for papers by Jinghan Xu Breakdown of academic impact, for papers by Xingzhi Guo
Rankless by CCL
2026